![Leah Monteiro](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Leah Monteiro worked as Senior Director-Communications & IR at KalVista Pharmaceuticals, Inc. from 2016 to 2021.
The career history includes roles as Vice President-Investor Relations at DURECT Corp., Senior Manager-Investor Relations at Genzyme Corp., Manager-Corporate Communications at Sesen Bio, Inc., and Vice President-Investor Relations & Communications at Solid Biosciences, Inc. from 2023 to 2024.
Former jobs include positions at KalVista Pharmaceuticals, Inc., DURECT Corp., Genzyme Corp., Sesen Bio, Inc., and Solid Biosciences, Inc.
Precedenti posizioni note di Leah Monteiro
| Società | Posizione | Fine |
|---|---|---|
| SOLID BIOSCIENCES INC. | Contatto Relazioni con gli Investitori | 30/04/2024 |
| KALVISTA PHARMA | Contatto Relazioni con gli Investitori | 01/12/2021 |
| CARISMA THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | 01/07/2016 |
| DURECT | Contatto Relazioni con gli Investitori | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Contatto Relazioni con gli Investitori | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
16
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
DURECT Corp.
 DURECT Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain and chronic diseases | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
KalVista Pharmaceuticals, Inc.
 KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
